• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Agilent Technologies (A) Trading At A Premium After New Launches?

    Simply Wall St·10/02/2026 22:27:29
    語音播報

    Agilent Technologies has delivered a strong share price run over the past few years, which puts the focus squarely on whether the current US$167.78 price makes sense when set against the cash flows the business is expected to generate. With a Discounted Cash Flow (DCF) estimate available, the key issue is how the recent market enthusiasm lines up with the actual money that can come back to shareholders over time.

    • Over the past 3 years the stock has gained 54.8%, which puts real weight on the question of whether that move is fully supported by the cash the business can produce.
    • Agilent's recent launches in automated sample preparation and clinical NGS quality control may support expectations for future cash generation by deepening its role in high value lab workflows.
    • What if you looked at Agilent Technologies through its earnings instead? See why Agilent Technologies's 32.8x P/E tells a different valuation story.

    For investors, the debate is whether Agilent Technologies' current share price is adequately backed by the intrinsic value suggested by its cash flows under a Discounted Cash Flow (DCF) view.

    If you want to compare Agilent Technologies with other businesses through the same cash flow lens, a focused screen of 30 high quality undervalued stocks can be helpful.

    Does Agilent Technologies Look Undervalued on Cash Flow?

    The Discounted Cash Flow (DCF) model here values Agilent Technologies on the cash it is expected to generate for shareholders. Latest twelve month free cash flow sits at about $1.21b, and the forecast path assumes that this figure grows over time rather than shrinks, with analyst projections rising through the early 2030s before easing into slower expansion.

    Under that set of cash flow estimates, the DCF output suggests an intrinsic value that is modestly above the current US$167.78 share price. Because the NovoStation sample preparation launch targets high value automated lab workflows, the market enthusiasm around that product helps explain why the stock already trades close to what these projected cash flows support. Find out what Agilent Technologies could be worth using our Discounted Cash Flow (DCF) estimate.

    The Agilent Technologies Narrative: What Would Justify Today's Price?

    Narratives on Simply Wall St pick up where this valuation puzzle leaves off by explaining which assumptions about Agilent Technologies' growth, margins, and earnings would need to hold for the share price to move meaningfully above or below where it trades today. Each scenario links a fair value estimate to a clear story about Agilent Technologies' possible catalysts and risks so you can track over time which version of events appears to be unfolding.

    One of the top community narratives on Agilent Technologies: roughly fairly valued

    "Strategic investments in higher-margin recurring revenue streams including consumables, software, services, and digital platforms are gaining traction…"

    Discover why this Narrative puts Agilent Technologies at roughly fairly valued.

    Agilent Technologies' valuation leaves one leadership question hanging

    Cash flows and share price only tell you so much about Agilent Technologies, because the people choosing where every dollar goes and how they are rewarded can tilt the whole story. See who runs Agilent Technologies and how they are paid.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.